CasLoc logo
All Cases PTAB Litigations UPC Oppositions

AbbVie Inc. v. Aurobindo Pharma Limited

1:14-cv-00959

Overview

Case Number 1:14-cv-00959
Filing Date 2014-07-18
Status Terminated
Termination Date 2014-12-03
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:0145
Jury Demand None

Parties

Defendant

Aurobindo Pharma USA Inc. Operating Company

Represented By

1 Attorneys Listed

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Aurobindo Pharma Limited NPE (University / Research)

Represented By

1 Attorneys Listed

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Plaintiff

AbbVie Inc. Operating Company

Represented By

2 Attorneys Listed

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Mary B. Graham

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 5 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 9 proceedings
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (5): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (9 found):
U.S. Courts: 9
U.S. District Court 2017-01-13
1:17-cv-00047

AbbVie Inc. v. Aurobindo Pharma Limited

Asserted Patent
Status: DED
U.S. District Court 2016-05-27
1:16-cv-00398

AbbVie Inc. v. Amneal Pharmaceuticals, LLC

Asserted Patent
Status: DED
U.S. District Court 2015-10-02
1:15-cv-00889

AbbVie Inc. v. Hetero USA Inc.

Asserted Patent
Status: DED
U.S. District Court 2014-09-25
1:14-cv-01236

AbbVie Inc. v. Mylan Pharmaceuticals Inc.

U.S. Family Sibling (["US8691878"])
Status: DED
U.S. District Court 2014-09-05
1:14-cv-01137

AbbVie Inc. v. Hetero Labs Limited

U.S. Family Sibling (["US8691878"])
Status: DED
U.S. District Court 2014-04-24
1:14-cv-00543

AbbVie Inc. v. Hetero USA Inc.

U.S. Family Sibling (["US8470347", "US8399015"])
Status: DED
U.S. District Court 2013-07-03
2:13-cv-00645

AbbVie Inc. v. Roxane Laboratories Inc.

Asserted Patent
Status: OHSD
U.S. District Court 2013-06-14
1:13-cv-01072

AbbVie Inc. v. Mylan Pharmaceuticals Inc.

Asserted Patent
Status: DED
U.S. District Court 2013-05-15
1:13-cv-00852

AbbVie Inc. v. Hetero USA Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

4 Patents

There are 4 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7148359
Polymorph of a pharmaceutical
Filed: 2005-05-04
Issued: 2006-12-12
Expired (Term Ended)
Expires: 2025-05-04
US7364752
Solid dispersion pharamaceutical formulations
Filed: 2000-11-10
Issued: 2008-04-29
Expired (Term Ended) +688d PTA
Expires: 2022-09-29
US8399015
Solid pharmaceutical dosage form
Filed: 2011-09-22
Issued: 2013-03-19
Active (4.8 yrs remaining)
Expires: 2031-09-22
US8691878
Solid pharmaceutical dosage form
Filed: 2012-11-12
Issued: 2014-04-08
Active (6.0 yrs remaining)
Expires: 2032-11-12

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

6

Dispositive

0

Granted

0

Denied

0

Pending / Review

3

Motions by Category

Procedural / Extension Motion 6

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to Complaint to December 3, 2014 - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc.....
Entry #11 • 2014-11-26 Document →
Procedural / Extension Motion Pending
SO ORDERED, re 11 STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to Complaint to December 3, 2014, filed by Aurobindo Pharma Limited, Aurobindo...
Entry #β€” • 2014-11-26
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to Complaint to November 26, 2014 - filed by AbbVie Inc.. (Fahnestock, Derek) Modified on 10/20/...
Entry #10 • 2014-10-20 Document →
Procedural / Extension Motion Pending
SO ORDERED, re 10 STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to Complaint to November 26, 2014, filed by AbbVie Inc. (Reset Answer Deadline...
Entry #β€” • 2014-10-20
Procedural / Extension Motion Pending
SO ORDERED, re 9 STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to the Complaint to October 26, 2014, filed by AbbVie Inc. (Reset Answer Deadli...
Entry #β€” • 2014-09-15
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to the Complaint to October 26, 2014 - filed by AbbVie Inc.. (Fahnestock, Derek) Modified on 9/1...
Entry #9 • 2014-09-12 Document →

Docket Entries

(20 total)
Pleading / Complaint

COMPLAINT - filed against Aurobindo Pharma Limited, Aurobindo Pharma USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1556376.) - filed by AbbVie Inc. (Attachments: # 1 Exhibit A-D, # 2 Civil Cover Sheet)(rwc) (Entered: 07/21/2014)

Entry #1 • 2014-07-18
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (rwc) (Entered: 07/21/2014)

Entry #2 • 2014-07-18
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/6/14. Date of Expiration of Patent: SEE ATTACHED FORM.Thirty Month Stay Deadline: 12/6/2016. (rwc) (Entered: 07/21/2014)

Entry #3 • 2014-07-18
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,148,359 B2; 7,364,752 B1; 8,399,015 B2; 8,691,878 B2. (rwc) (Entered: 07/21/2014)

Entry #4 • 2014-07-18
1

Summons Issued with Magistrate Consent Notice attached as to Aurobindo Pharma Limited on 7/21/2014; Aurobindo Pharma USA Inc. on 7/21/2014. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (rwc)

Entry #5 • 2014-07-21
1
No Actions

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc